Home | Welcome to Contract Pharma   
Last Updated Saturday, May 18 2013
Print

Industry News

Related Searches:

Filter by:

December 28, 2009
Lilly and Kowa Pharmaceuticals America, a subsidiary of Kowa Co., Ltd., have entered into a co-promotion agreement to commercialize Livalo (pitavastatin) in the U.S. and entered into a licensing agreement in Latin America.   Read More »
December 28, 2009
Teva-KOWA Pharma Co., Ltd. has signed a definitive agreement to acquire a majority (at least 66.7%) of the outstanding shares of Taisho Pharmaceutical Industries, Ltd.   Read More »
December 28, 2009
The United States District Court in Boston has entered final judgment ending the five-year patent infringement dispute between Amgen and Roche.   Read More »
December 22, 2009
Sanofi builds U.S. OTC presence with $1.9 billion buy.   Read More »
December 22, 2009
Durata scquires Pfizer unit for antibiotic candidate.   Read More »
December 16, 2009
Hospira will acquire the generic injectable finished-dosage form pharmaceuticals business of India-based Orchid for $400 million.   Read More »
December 16, 2009
Covance has opened new clinical development offices in Seoul and Mumbai and has expanded offices in Tokyo and Hong Kong   Read More »
December 15, 2009
Patheon has successfully released the first commercial shipments of Zogenix's Sumavel DosePro   Read More »
December 15, 2009
Abbott will acquire STARLIMS for $123 million.   Read More »
December 14, 2009
ICON has expanded its European Central Laboratory.   Read More »
December 14, 2009
Cubist may spend as much as $400 million on Calixa.   Read More »
December 10, 2009
Patheon will consolidate PR operations into Manati site, either losing or selling Caguas plant.   Read More »
December 9, 2009
Particle Sciences has expanded its HPC handling capabilities with help from IES Engineers.   Read More »
December 7, 2009
Celgene Corporation will acquire Gloucester Pharmaceuticals for $340 million in cash and as much as $300 million in milestone payments.   Read More »
December 3, 2009
Shri Thanedar, Ph.D., has been named chief executive officer of Azopharma Product Development Group.   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On